Cargando…
The amyloid precursor protein derivative, APP96-110, is efficacious following intravenous administration after traumatic brain injury
Following traumatic brain injury (TBI) neurological damage is ongoing through a complex cascade of primary and secondary injury events in the ensuing minutes, days and weeks. The delayed nature of secondary injury provides a valuable window of opportunity to limit the consequences with a timely trea...
Autores principales: | Plummer, Stephanie L., Corrigan, Frances, Thornton, Emma, Woenig, Joshua A., Vink, Robert, Cappai, Roberto, Van Den Heuvel, Corinna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761886/ https://www.ncbi.nlm.nih.gov/pubmed/29320530 http://dx.doi.org/10.1371/journal.pone.0190449 |
Ejemplares similares
-
The Neuroprotective Properties of the Amyloid Precursor Protein Following Traumatic Brain Injury
por: Plummer, Stephanie, et al.
Publicado: (2016) -
Effects of amyloid precursor protein peptide APP96-110, alone or with human mesenchymal stromal cells, on recovery after spinal cord injury
por: Hodgetts, Stuart I., et al.
Publicado: (2021) -
Assessment of R18, COG1410, and APP96-110 in Excitotoxicity and Traumatic Brain Injury
por: Chiu, Li Shan, et al.
Publicado: (2017) -
Amyloid Precursor Protein (APP) and GABAergic Neurotransmission
por: Tang, Bor Luen
Publicado: (2019) -
Chronic traumatic encephalopathy: genes load the gun and repeated concussion pulls the trigger
por: Vink, Robert, et al.
Publicado: (2022)